Why the study?
What is the clinical value and limitations of monitoring antihypertensive drug therapy?
What is the clinical value and limitations of monitoring antihypertensive drug therapy?
This review outlines a rational, stepwise approach to antihypertensive therapy and discusses the role of therapeutic drug monitoring.
No takes yet. Share an insight, caveat, or question.
May support targeted monitoring in resistant hypertension; leaves open routine adoption absent prospective trials.
Bateman et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: